Skip to main content
. 2020 Oct 28;11:5439. doi: 10.1038/s41467-020-19288-6

Fig. 2. Effects of KRAS-induced immune modulation in cancer.

Fig. 2

Multiple intracellular downstream effects of KRAS on chemokine production (CXCL3), cytokine production, MHC expression and ligand expression are shown. Mutations are indicated by a red star symbol (activating mutations in MYC, inactivating mutations in TP53 and STK11/LKB1). The dotted line indicates co-occurring mutations.